Xiaoqinglong decoction suppresses childhood cough variant asthma and inhibited the body inflammatory response by regulating IL-6/STAT3 signalling pathway

Xiaoqinglong decoction (XQLD) is widely used clinically in the treatment of childhood cough variant asthma (CVA). However, its potential mechanism is still unknown. In the present study, the authors investigate the biological network and signalling pathway of XQLD in treatment of childhood CVA using...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yuzhe, Li, Xing, Zhang, Yuanjie, Yan, Zilong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617864/
https://www.ncbi.nlm.nih.gov/pubmed/37915641
http://dx.doi.org/10.1097/MS9.0000000000001326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617864/
https://www.ncbi.nlm.nih.gov/pubmed/37915641
http://dx.doi.org/10.1097/MS9.0000000000001326

Ejemplares similares